Edit |   |
---|---|
Antigenic Specificity | CD154, Human (Letolizumab biosimilar) |
Clone | Letolizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | (VH-CH2-CH3)2 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD154 Recombinant Antibody (Letolizumab). Letolizumab (INN, development code BMS-986004) is a humanized monoclonal antibody designed for the treatment of inflammatory diseases. This drug was developed by Bristol-Myers Squibb. |
Immunogen | n/a |
Other Names | Anti-CD154 Recombinant Antibody, Research Grade Letolizumab, Anti-Human CD154 Recombinant Antibody(Letolizumab), BMS-986004, Antibody Drug Analogues, Monoclonal Antibody, YR1450, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1450981-87-9 |
Catalog # | YR1450 |
Price | please inquire |
Order / More Info | CD154, Human (Letolizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |